Teladoc Health IncTDOC
Price$5.67Intrinsic value$15.11166% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.5B-3.1% YoYTTM through 30 Jun 2026
Net Income -$177.4MTTM through 30 Jun 2026
Free Cash Flow $253.7MTTM through 30 Jun 2026

Margins

Current
Gross Margin52.8%
EBITDA Margin4.6%
Operating Margin-10.1%
Net Margin-7.1%

Returns

-12.4%ROE
-3.1%ROA

Balance Sheet Health

Debt / Equity0.75x
Current Ratio2.80x
Net Debt$245.1M
Cash & Equivalents$774.3M

Quality Metrics

Altman Z-Score-7.34
Piotroski F-Score3 / 9
FCF Margin10.2%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $2.5B
Diluted EPS-$0.99TTM
'19'20'21'22'23'24'25
FY2025: $-1.14

Dividend

No dividend

Capital Allocation

R&D Spend$269.9M
Capex Intensity0.3%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.